JAMELAH MORTON: Open Payments
NPI 1881833804 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 37 payments from 8 companies in 2025. Trend: 2023 $479 · 2024 $1,908 · 2025 $1,494
Food & beverage: $1,494
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $644 |
| AstraZeneca Pharmaceuticals LP | 9 | $298 |
| Aesculap, Inc. | 7 | $250 |
| LivaNova USA, Inc. | 2 | $132 |
| PFIZER INC. | 4 | $90 |
| Janssen Biotech, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: WAINUA, XABO, Fintepla, Briviact, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, ELIQUIS, Nayzilam, RYBREVANT.
Industry payments across FL — which companies pay providers there.
